STAG1 and benign prostatic hyperplasia: Selective α1 receptor antagonists (sα1-RAs) are widely prescribed for relieving lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH), a most frequent disease in aging men (Lowe, 2004).